药时代BD项目 | 欧洲药企寻找免疫学(immunology)和神经病学(neurology)项目

项目编号:DT-BD-20200412-011

药时代BD项目 | 中国大型制药企业寻找大陆以外医药项目

项目编号:DT-BD-20200412-011

Project Number: DT-BD-20200412-011

项目内容:欧洲药企寻找免疫学(immunology)和神经病学(neurology)项目。专注于免疫学自身免疫性疾病,而非免疫肿瘤学)和神经病学癫痫帕金森氏症和神经退行性疾病)领域,对神经系统疾病的基因疗法(和细胞疗法)感兴趣,也对蛋白质降解等新形式感兴趣。

Request: focuses on the area of immunology (autoimmune diseases, not immuno oncology ), and neurology (epilepsy, Parkinson’s and neurodegeneration), interested in gene therapy (and cell therapy) for neurological disorders, also in the new modality of  protein degradation.

目标领域:专注于免疫学自身免疫性疾病,而非免疫肿瘤学)和神经病学(癫痫、帕金森氏症和神经退行性疾病)领域

Target area: focuses on the area of immunology (autoimmune diseases, not immuno oncology ), and neurology (epilepsy, Parkinson’s and neurodegeneration)

目标阶段:全部,只要创新程度高

Target stage: all stages, as long as innovative

药物类别:小分子药、生物药细胞疗法基因疗法,等等

Drug category: small molecule drugs, biological drugs, cell therapy, gene therapy

目标权益:最好是全球权益

Target right: Global rights ideally

如果您对该合作机会感兴趣,欢迎与我们联系!我们将与您详细探讨。谢谢!

If you are interested in introducing this collaboration opportunity, please contact us. We will discuss with you in details. Thank you very much!

联系人 (Contact):Will

电话 (Mobile):13564569657

微信 (Wechat):27674131

邮箱 (E-mail):BD@drugtimes.cn

官网:https://www.drugtimes.cn

邮件主题请注明:项目编号:DT-BD-20200412-011

In the e-mail subject, please include “Project Number: DT-BD-20200412-011”

药时代BD项目 | 欧美公司购买中国创新药项目

发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权

发表评论

登录后才能评论
分享本页
返回顶部